/Merck%20%26%20Co%20Inc%20billboard-by%20monticello%20via%20Shutterstock.jpg)
Rahway, New Jersey-based Merck & Co., Inc. (MRK) provides health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. With a market cap of $214.8 billion, Merck operates through Pharmaceutical, Animal Health, and Other segments and serves in nearly 140 countries across the globe.
The healthcare giant is gearing up to unveil its third-quarter results before the market opens on Thursday, Oct. 30. Ahead of the event, analysts expect MRK to deliver a profit of $2.37 per share, up 51% from $1.57 per share reported in the year-ago quarter. Further, the company has a solid earnings surprise history and has surpassed the Street’s bottom-line estimates in each of the past four quarters.
